Maple Grove, MN, United States of America

Randal A Seburg

This inventor holds 8 USPTO granted patents and 3 published patent applications. Top assignees: Clexio Biosciences Ltd., Cima Labs Inc.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Randal A Seburg. Retrieved from https://idiyas.com/inventor/randal-a-seburg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Maple Grove, MN (US) (2017 - 2023)
  • Louisville, KY (US) (2022 - 2024)

Company Filing History:


Years Active: 2017-2026

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Randal A. Seburg: Innovator in Abuse-Deterrent Dosage Forms

Introduction

Randal A. Seburg is a notable inventor based in Maple Grove, MN (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of seven patents, focusing primarily on abuse-deterrent dosage forms that enhance patient safety and reduce the potential for misuse.

Latest Patents

Seburg's latest patents include innovative formulations such as "Abuse-deterrent dosage forms containing esketamine." This patent discloses immediate release oral dosage forms designed with abuse-deterrent and abuse-resistant features. These dosage forms aim to deter abuse by preventing the ingestion of multiple individual doses, thereby protecting against overdose in cases of accidental or intentional misuse. Additionally, these formulations exhibit properties that resist abuse when physically manipulated or administered inappropriately. Another significant patent is "Immediate release abuse-deterrent granulated dosage forms," which similarly focuses on providing protection from overdose and deterring abuse through its unique formulation.

Career Highlights

Throughout his career, Randal A. Seburg has worked with prominent companies in the pharmaceutical industry, including Clexio Biosciences Ltd. and Cima Labs Inc. His work has significantly impacted the development of safer medication options, particularly in the context of opioid use and abuse.

Collaborations

Seburg has collaborated with notable professionals in his field, including Derek V. Moe and Dinesh K. Haswani. These collaborations have contributed to the advancement of his innovative work in abuse-deterrent technologies.

Conclusion

Randal A. Seburg's contributions to the field of pharmaceuticals, particularly in the development of abuse-deterrent dosage forms, highlight his commitment to enhancing patient safety. His innovative patents and collaborations reflect a dedication to addressing critical issues in medication misuse and overdose prevention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…